Physician profile
Mary Suzanne Basey
NPI 1407856941
$1,059.17
in general payments reported to CMS, 2019-2025
16 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.97 · 2020: $74.48 · 2021: $96.28 · 2022: $120 · 2023: $218 · 2024: $260 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $203.78 | 2023-2025 | Azstarys |
| Glaxosmithkline, LLC. | $146.47 | 2019-2023 | Bexsero |
| Sanofi Pasteur INC. | $116.91 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.72 | 2020-2021 | |
| Pfizer INC. | $75.68 | 2024-2025 | |
| Phadia US INC. | $74.58 | 2024-2025 | Immunocap |
| Ironshore Pharmaceuticals INC. | $64.62 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $59.84 | 2023-2024 | Qelbree, Qelbree |
| Tris Pharma INC | $38.96 | 2021-2022 | |
| Cumberland Pharmaceuticals, INC. | $35.50 | 2025 | Kristalose |
| Collegium Pharmaceutical, INC. | $34.08 | 2025 | Jornay Pm |
| Alk-Abello, INC | $27.13 | 2023 | Ragwitek, Odactra, Grastek |
| Merck Sharp & Dohme LLC | $26.87 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $16.83 | 2024 | Ycanth |
| Abbott Laboratories | $13.92 | 2025 | Id Now Strep A 2 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $11.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Basey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.